Kennosuke Tsuda
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Kennosuke Tsuda has a total of 54 co-authors. Here are the top co-authors by number of shared publications:
- Osuke Iwata
Center for Human Development and Family Science, Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan
5 shared publications - Sachiko Iwata
Center for Human Development and Family Science, Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan
3 shared publications - Shinji Saitoh
Department of Pediatrics and Neonatology, Nagoya City University Graduate School of Medical Sciences, Nagoya 467-8601, Japan
3 shared publications Akihito Takahashi
Department of Pediatrics Kurashiki Central Hospital Okayama Japan
2 shared publications- Akihito Takeuchi
Division of Neonatology, NHO Okayama Medical Center, Okayama, Japan
2 shared publications - Jun Shibasaki
Department of Neonatology, Kanagawa Children's Medical Center, Yokohama, Japan
2 shared publications
Latest Publications
- Open Access
- 20 February 2026
- Published by MDPI AG in Biosensors
- Vol. 16 (2) , 127
Investigating Roles of Cerebral Blood Flow to Maintain Thermal Stability of Neonatal Brain Against Cold Stress Using Non-Invasive Probes for Brain Perfusion and Temperature Gradient
Background: Brain temperature is an important determinant of neurological outcomes in ill infants, yet contributions of environmental temperature and cerebral blood flow remain uncovered because of the lack of non-invasive probes. Methods: Using non-invasive cot-side probes, we examined how cerebral blood flow influences brain temperature during mild cold stress induced by incubator-to-cot transfer. We studied 43 clinically stable infants in a tertiary neonatal intensive care unit. After cot transfer, infants were routinely fitted with knit caps and wrapped in cotton blankets. Scalp and superficial and deep brain temperatures were measured using infrared and zero-heat-flux thermometers, and superior vena cava (SVC) flow—a proxy for cerebral blood flow—was assessed using Doppler velocimetry before, immediately after, and 2 h after transfer, adjusting for rectal temperature. Results: Ambient temperature decreased from 29.7 (SD 0.8) °C to 26.8 (SD 0.9) °C, while rectal temperature remained stable. Scalp and brain temperatures declined after transfer but superficial and deep brain temperatures returned to baseline after 2 h of cap use. The regression coefficient between SVC flow and superficial brain temperature shifted from −0.176 (95% CI, −0.386 to 0.035) to 0.239 (−0.280 to 0.759) after transfer (difference: 0.415 [0.106 to 0.724]; p = 0.009), and then returned to baseline after 2 h (−0.079 [−0.528 to 0.372]). Conclusions: Relationships between brain temperature and perfusion were successfully monitored using non-invasive cot-side biosensors; cerebral blood flow appears to shift from facilitating heat dissipation in warm conditions to supporting heat delivery during cold stress. These findings underscore the physiological role of cerebral blood flow in maintaining brain temperature.
- 20 February 2026
- Published by MDPI AG in Biosensors
- Vol. 16 (2) , 127
Open AccessInvestigating Roles of Cerebral Blood Flow to Maintain Thermal Stability of Neonatal Brain Against Cold Stress Using Non-Invasive Probes for Brain Perfusion and Temperature Gradient
Background: Brain temperature is an important determinant of neurological outcomes in ill infants, yet contributions of environmental temperature and cerebral blood flow remain uncovered because of the lack of non-invasive probes. Methods: Using non-invasive cot-side probes, we examined how cerebral blood flow influences brain temperature during mild cold stress induced by incubator-to-cot transfer. We studied 43 clinically stable infants in a tertiary neonatal intensive care unit. After cot transfer, infants were routinely fitted with knit caps and wrapped in cotton blankets. Scalp and superficial and deep brain temperatures were measured using infrared and zero-heat-flux thermometers, and superior vena cava (SVC) flow—a proxy for cerebral blood flow—was assessed using Doppler velocimetry before, immediately after, and 2 h after transfer, adjusting for rectal temperature. Results: Ambient temperature decreased from 29.7 (SD 0.8) °C to 26.8 (SD 0.9) °C, while rectal temperature remained stable. Scalp and brain temperatures declined after transfer but superficial and deep brain temperatures returned to baseline after 2 h of cap use. The regression coefficient between SVC flow and superficial brain temperature shifted from −0.176 (95% CI, −0.386 to 0.035) to 0.239 (−0.280 to 0.759) after transfer (difference: 0.415 [0.106 to 0.724]; p = 0.009), and then returned to baseline after 2 h (−0.079 [−0.528 to 0.372]). Conclusions: Relationships between brain temperature and perfusion were successfully monitored using non-invasive cot-side biosensors; cerebral blood flow appears to shift from facilitating heat dissipation in warm conditions to supporting heat delivery during cold stress. These findings underscore the physiological role of cerebral blood flow in maintaining brain temperature.
- Open Access
- 17 December 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (12) , 818
Temporal Changes in Brain Light Scattering and Its Independent Variables Within 2 Days of Life
The reduced scattering coefficient (μs′), measured using time-resolved near-infrared spectroscopy (TR-NIRS) has been linked to brain water diffusion assessed by diffusion tensor imaging, suggesting its potential as a bedside marker of cerebral microstructure. However, the physiological determinants of μs′ and its early postnatal changes remain unclear. This study examined clinical associations with cerebral μs′ in healthy term newborn infants during the first 2 postnatal days. Eighteen newborn infants underwent TR-NIRS at 6 and 36 h postnatally. Associations between μs′ and 14 clinical variables were analysed using generalised estimating equations. Median μs′ was 7.395 cm−1 (IQR: 6.140–8.159) at 6 h and 7.112 cm−1 (IQR: 6.473–7.410) at 36 h, with no significant difference (p = 0.327). Male sex was associated with higher μs′ (regression coefficient = 0.895, p = 0.007), whereas caesarean delivery (regression coefficient = −0.969, p = 0.012) was associated with lower μs′. A significant interaction between caesarean delivery and postnatal age indicated that the negative effect diminished between 6 and 36 h after birth (difference = 0.057, p = 0.016). These findings suggest delivery mode transiently influences brain scattering, whereas the effect of sex remains stable, supporting further investigation of TR-NIRS as an acute-phase cerebral marker.
- 17 December 2025
- Published by MDPI AG in Biosensors
- Vol. 15 (12) , 818
Open AccessTemporal Changes in Brain Light Scattering and Its Independent Variables Within 2 Days of Life
The reduced scattering coefficient (μs′), measured using time-resolved near-infrared spectroscopy (TR-NIRS) has been linked to brain water diffusion assessed by diffusion tensor imaging, suggesting its potential as a bedside marker of cerebral microstructure. However, the physiological determinants of μs′ and its early postnatal changes remain unclear. This study examined clinical associations with cerebral μs′ in healthy term newborn infants during the first 2 postnatal days. Eighteen newborn infants underwent TR-NIRS at 6 and 36 h postnatally. Associations between μs′ and 14 clinical variables were analysed using generalised estimating equations. Median μs′ was 7.395 cm−1 (IQR: 6.140–8.159) at 6 h and 7.112 cm−1 (IQR: 6.473–7.410) at 36 h, with no significant difference (p = 0.327). Male sex was associated with higher μs′ (regression coefficient = 0.895, p = 0.007), whereas caesarean delivery (regression coefficient = −0.969, p = 0.012) was associated with lower μs′. A significant interaction between caesarean delivery and postnatal age indicated that the negative effect diminished between 6 and 36 h after birth (difference = 0.057, p = 0.016). These findings suggest delivery mode transiently influences brain scattering, whereas the effect of sex remains stable, supporting further investigation of TR-NIRS as an acute-phase cerebral marker.
- Open Access
- 6 November 2025
- Published by Elsevier in Neuropharmacology
- Vol. 283, 110763
Caffeine Citrate does not reduce brain injury following inflammation-amplified hypoxia ischaemia or hypoxia ischaemia in the Newborn Piglet Model
- 6 November 2025
- Published by Elsevier in Neuropharmacology
- Vol. 283, 110763
Open AccessCaffeine Citrate does not reduce brain injury following inflammation-amplified hypoxia ischaemia or hypoxia ischaemia in the Newborn Piglet Model
- Open Access
- 1 April 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (7) , 881
Incidence and Risk Factors of White Matter Lesions in Moderate and Late Preterm Infants
Background: Moderate and late preterm infants (32–36 weeks of gestation) are at significant risk of developmental impairments. Incidence of white matter lesions, which are associated with developmental impairments in very preterm infants, remains underreported in this population. This study aimed to assess the incidence and clinical risk factors associated with brain lesions, particularly white matter lesions, in moderate and late preterm infants using term-equivalent MRI. Methods: This prospective observational study included 195 preterm infants born at 32+0–36+6 weeks of gestation and admitted to a tertiary NICU between 2019 and 2020. MRI findings at term-equivalent age were evaluated. Clinical risk factors were analysed using logistic regression. Results: Among the 195 infants, 23.6% had brain lesions on MRI, with white matter lesions (73.9%), specifically punctate white matter lesions, being the most common form of lesions. Vaginal delivery (odds ratio (OR) = 3.102, 95% confidence interval (CI) = 1.250–7.696, p = 0.015), larger birth weight z-scores (OR = 1.702, 95% CI = 1.118–2.591, p = 0.013), and intubation (OR = 2.948, 95% CI = 1.269–6.850, p = 0.012) were significant risk factors for white matter lesions. Conclusions: White matter lesions, particularly punctate white matter lesions, are common in moderate and late preterm infants. These lesions are associated with perinatal factors suggestive of delayed transition and inflammation. Future research should focus on detailed clinical care measures and neurodevelopmental assessments to identify modifiable risk factors for brain injury.
- 1 April 2025
- Published by MDPI AG in Diagnostics
- Vol. 15 (7) , 881
Open AccessIncidence and Risk Factors of White Matter Lesions in Moderate and Late Preterm Infants
Background: Moderate and late preterm infants (32–36 weeks of gestation) are at significant risk of developmental impairments. Incidence of white matter lesions, which are associated with developmental impairments in very preterm infants, remains underreported in this population. This study aimed to assess the incidence and clinical risk factors associated with brain lesions, particularly white matter lesions, in moderate and late preterm infants using term-equivalent MRI. Methods: This prospective observational study included 195 preterm infants born at 32+0–36+6 weeks of gestation and admitted to a tertiary NICU between 2019 and 2020. MRI findings at term-equivalent age were evaluated. Clinical risk factors were analysed using logistic regression. Results: Among the 195 infants, 23.6% had brain lesions on MRI, with white matter lesions (73.9%), specifically punctate white matter lesions, being the most common form of lesions. Vaginal delivery (odds ratio (OR) = 3.102, 95% confidence interval (CI) = 1.250–7.696, p = 0.015), larger birth weight z-scores (OR = 1.702, 95% CI = 1.118–2.591, p = 0.013), and intubation (OR = 2.948, 95% CI = 1.269–6.850, p = 0.012) were significant risk factors for white matter lesions. Conclusions: White matter lesions, particularly punctate white matter lesions, are common in moderate and late preterm infants. These lesions are associated with perinatal factors suggestive of delayed transition and inflammation. Future research should focus on detailed clinical care measures and neurodevelopmental assessments to identify modifiable risk factors for brain injury.
- Open Access
- 14 October 2024
- Published by Oxford University Press (OUP) in Stem Cells Translational Medicine
- Vol. 13 (11) , 1053-1066
Safety and tolerability of a Muse cell-based product in neonatal hypoxic-ischemic encephalopathy with therapeutic hypothermia (SHIELD trial)
Hypoxic–ischemic encephalopathy (HIE), associated with high mortality and neurological sequelae, lacks established treatment except therapeutic hypothermia. Clinical-grade multilineage-differentiating stress-enduring (Muse) cells (CL2020) demonstrated safety and efficacy in nonclinical HIE rat models, thereby leading to an investigator-initiated clinical trial to evaluate CL2020 safety and tolerability in neonatal HIE as a single-center open-label dose-escalation study with 9 neonates with moderate-to-severe HIE who received therapeutic hypothermia. Each patient received a single intravenous injection of CL2020 cells between 5 and 14 days of age. The low-dose (3 patients) and high-dose (6 patients) groups received 1.5 × 106 and 1.5 × 107 cells/dose, respectively. The occurrence of any adverse event within 12 weeks following CL2020 administration was the primary endpoint of this trial. No significant changes in physiological signs including heart rate, blood pressure, and oxygen saturation were observed during or after administration. The only adverse event that may be related to cell administration was a mild γ-glutamyltransferase level elevation in one neonate, which spontaneously resolved without any treatment. All patients enrolled in the trial survived, and normal developmental quotients (≥ 85) in all 3 domains of the Kyoto Scale of Psychological Development 2001 were observed in 67% of the patients in this trial. CL2020 administration was demonstrated to be safe and tolerable for neonates with HIE. Considering the small number of patients, a randomized controlled confirmatory study is warranted to verify these preliminary findings and evaluate the efficacy of this therapy.
- 14 October 2024
- Published by Oxford University Press (OUP) in Stem Cells Translational Medicine
- Vol. 13 (11) , 1053-1066
Open AccessSafety and tolerability of a Muse cell-based product in neonatal hypoxic-ischemic encephalopathy with therapeutic hypothermia (SHIELD trial)
Hypoxic–ischemic encephalopathy (HIE), associated with high mortality and neurological sequelae, lacks established treatment except therapeutic hypothermia. Clinical-grade multilineage-differentiating stress-enduring (Muse) cells (CL2020) demonstrated safety and efficacy in nonclinical HIE rat models, thereby leading to an investigator-initiated clinical trial to evaluate CL2020 safety and tolerability in neonatal HIE as a single-center open-label dose-escalation study with 9 neonates with moderate-to-severe HIE who received therapeutic hypothermia. Each patient received a single intravenous injection of CL2020 cells between 5 and 14 days of age. The low-dose (3 patients) and high-dose (6 patients) groups received 1.5 × 106 and 1.5 × 107 cells/dose, respectively. The occurrence of any adverse event within 12 weeks following CL2020 administration was the primary endpoint of this trial. No significant changes in physiological signs including heart rate, blood pressure, and oxygen saturation were observed during or after administration. The only adverse event that may be related to cell administration was a mild γ-glutamyltransferase level elevation in one neonate, which spontaneously resolved without any treatment. All patients enrolled in the trial survived, and normal developmental quotients (≥ 85) in all 3 domains of the Kyoto Scale of Psychological Development 2001 were observed in 67% of the patients in this trial. CL2020 administration was demonstrated to be safe and tolerable for neonates with HIE. Considering the small number of patients, a randomized controlled confirmatory study is warranted to verify these preliminary findings and evaluate the efficacy of this therapy.
- 7 February 2023
- Published by Wiley in Acta Paediatrica
- Vol. 112 (4) , 734-741
Prolonged requirements for mechanical ventilation and tube feeding support predicted 18‐month outcomes for neonatal encephalopathy
AimWe evaluated the predictive ability of prolonged requirements for mechanical ventilation or tube feeding support for 18-month composite outcomes in infants with hypoxic-ischaemic encephalopathy treated with hypothermia. MethodsThis retrospective, nationwide, observational study focused on newborn infants registered in Japan's Baby Cooling Registry between 1 January 2012 and 31 December 2016. The adverse outcomes were defined as death or survival with cerebral palsy, visual or auditory impairment or the requirement for mechanical ventilation or tube feeding at 18 months of age. ResultsAdverse outcomes occurred in 165 (28%) of the 591 children in the final cohort. These were predicted by prolonged dependence on mechanical ventilation or tube feeding for more than seven and more than 14 days. The respective values were positive predictive value 0.34 (95% CI 0.33-0.34) and 0.60 (95% CI 0.56-0.62), negative predictive value 0.97 (95% CI 0.91-0.99) and 0.93 (95% CI 0.90-0.95) and area under the curve 0.59 (95% CI 0.54-0.64) and 0.81 (95% CI 0.77-0.85). ConclusionProlonged dependence on mechanical ventilation or tube feeding for more than 14 days may be useful in predicting 18-month outcomes in newborn infants who have received therapeutic hypothermia.
- 7 February 2023
- Published by Wiley in Acta Paediatrica
- Vol. 112 (4) , 734-741
Prolonged requirements for mechanical ventilation and tube feeding support predicted 18‐month outcomes for neonatal encephalopathy
AimWe evaluated the predictive ability of prolonged requirements for mechanical ventilation or tube feeding support for 18-month composite outcomes in infants with hypoxic-ischaemic encephalopathy treated with hypothermia. MethodsThis retrospective, nationwide, observational study focused on newborn infants registered in Japan's Baby Cooling Registry between 1 January 2012 and 31 December 2016. The adverse outcomes were defined as death or survival with cerebral palsy, visual or auditory impairment or the requirement for mechanical ventilation or tube feeding at 18 months of age. ResultsAdverse outcomes occurred in 165 (28%) of the 591 children in the final cohort. These were predicted by prolonged dependence on mechanical ventilation or tube feeding for more than seven and more than 14 days. The respective values were positive predictive value 0.34 (95% CI 0.33-0.34) and 0.60 (95% CI 0.56-0.62), negative predictive value 0.97 (95% CI 0.91-0.99) and 0.93 (95% CI 0.90-0.95) and area under the curve 0.59 (95% CI 0.54-0.64) and 0.81 (95% CI 0.77-0.85). ConclusionProlonged dependence on mechanical ventilation or tube feeding for more than 14 days may be useful in predicting 18-month outcomes in newborn infants who have received therapeutic hypothermia.
- Open Access
- 13 May 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-8
Three-year outcome following neonatal encephalopathy in a high-survival cohort
This study investigated the 3-year clinical outcomes in relation to the severity of encephalopathy in high-survival infants who underwent therapeutic hypothermia. This retrospective observational study was conducted in level II/III neonatal intensive care units in Japan. The nationwide cohort included 474 infants registered in the Baby Cooling Registry of Japan between January 2012 and December 2016. Clinical characteristics, mortality rate and severe neurological impairment at age 3 years were evaluated. Of the infants, 48 (10.4%), 291 (63.1%) and 122 (26.5%) had mild, moderate and severe encephalopathy, respectively, upon admission. By age 3, 53 (11.2%) infants died, whereas 110 (26.1%) developed major disabilities. The mild group survived up to age 3. In the moderate group, 13 (4.5%) died and 44 (15.8%) developed major disabilities. In the severe group, 39 (32.0%) died by age 3. Adverse outcomes were observed in 100 (82.0%) infants. Mortality was relatively low in all subgroups, but the incidence of major disabilities was relatively high in the severe group. The relatively low mortality and high morbidity may be due to Japanese social and ethical norms, which rarely encourage the withdrawal of intensive life support. Cultural and ethical backgrounds may need to be considered when assessing the effect of therapeutic interventions.
- 13 May 2022
- Published by Springer Nature in Scientific Reports
- Vol. 12 (1) , 1-8
Open AccessThree-year outcome following neonatal encephalopathy in a high-survival cohort
This study investigated the 3-year clinical outcomes in relation to the severity of encephalopathy in high-survival infants who underwent therapeutic hypothermia. This retrospective observational study was conducted in level II/III neonatal intensive care units in Japan. The nationwide cohort included 474 infants registered in the Baby Cooling Registry of Japan between January 2012 and December 2016. Clinical characteristics, mortality rate and severe neurological impairment at age 3 years were evaluated. Of the infants, 48 (10.4%), 291 (63.1%) and 122 (26.5%) had mild, moderate and severe encephalopathy, respectively, upon admission. By age 3, 53 (11.2%) infants died, whereas 110 (26.1%) developed major disabilities. The mild group survived up to age 3. In the moderate group, 13 (4.5%) died and 44 (15.8%) developed major disabilities. In the severe group, 39 (32.0%) died by age 3. Adverse outcomes were observed in 100 (82.0%) infants. Mortality was relatively low in all subgroups, but the incidence of major disabilities was relatively high in the severe group. The relatively low mortality and high morbidity may be due to Japanese social and ethical norms, which rarely encourage the withdrawal of intensive life support. Cultural and ethical backgrounds may need to be considered when assessing the effect of therapeutic interventions.
- 15 May 2019
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 105 (1) , 64-68
Outcomes related to 10-min Apgar scores of zero in Japan
Objective Apgar scores of zero at 10 min strongly predict mortality and morbidity in infants. However, recent data reported improved outcomes among infants with Apgar scores of zero at 10 min. We aimed to review the mortality rate and neurodevelopmental outcomes of infants with Apgar scores of zero at 10 min in Japan. Design Observational study. Patients Twenty-eight of 768 infants registered in the Baby Cooling Registry of Japan between 2012 and 2016, at >34 weeks’ gestation, with Apgar scores of zero at 10 min who were treated with therapeutic hypothermia. Interventions We investigated the time of first heartbeat detection in infants with favourable outcomes and who had neurodevelopmental impairments or died. Main outcome measures Clinical characteristics, mortality rate and neurodevelopmental outcomes at 18–22 months of age were evaluated. Results Nine (32%) of the 28 infants died before 18 months of age; 16 (57%) survived, but with severe disabilities and 3 (11%) survived without moderate-to-severe disabilities. At 20 min after birth, 14 of 27 infants (52%) did not have a first heartbeat, 13 of them died or had severe disabilities and one infant, who had the first heartbeat at 20 min, survived without disability. Conclusion Our study adds to the recent evidence that neurodevelopmental outcomes among infants with Apgar scores of zero at 10 min may not be uniformly poor. However, in our study, all infants with their first heartbeat after 20 min of age died or had severe disabilities.
- 15 May 2019
- Published by BMJ in Archives of Disease in Childhood - Fetal and Neonatal Edition
- Vol. 105 (1) , 64-68
Outcomes related to 10-min Apgar scores of zero in Japan
Objective Apgar scores of zero at 10 min strongly predict mortality and morbidity in infants. However, recent data reported improved outcomes among infants with Apgar scores of zero at 10 min. We aimed to review the mortality rate and neurodevelopmental outcomes of infants with Apgar scores of zero at 10 min in Japan. Design Observational study. Patients Twenty-eight of 768 infants registered in the Baby Cooling Registry of Japan between 2012 and 2016, at >34 weeks’ gestation, with Apgar scores of zero at 10 min who were treated with therapeutic hypothermia. Interventions We investigated the time of first heartbeat detection in infants with favourable outcomes and who had neurodevelopmental impairments or died. Main outcome measures Clinical characteristics, mortality rate and neurodevelopmental outcomes at 18–22 months of age were evaluated. Results Nine (32%) of the 28 infants died before 18 months of age; 16 (57%) survived, but with severe disabilities and 3 (11%) survived without moderate-to-severe disabilities. At 20 min after birth, 14 of 27 infants (52%) did not have a first heartbeat, 13 of them died or had severe disabilities and one infant, who had the first heartbeat at 20 min, survived without disability. Conclusion Our study adds to the recent evidence that neurodevelopmental outcomes among infants with Apgar scores of zero at 10 min may not be uniformly poor. However, in our study, all infants with their first heartbeat after 20 min of age died or had severe disabilities.